Dominic Piscitelli - 31 Mar 2022 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
Chief Financial Officer
Signature
/s/ Christian Kuhlen, attorney-in-fact
Issuer symbol
ORIC
Transactions as of
31 Mar 2022
Transactions value $
$321,624
Form type
4
Filing time
31 Mar 2022, 20:51:58 UTC
Previous filing
02 Feb 2022
Next filing
21 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Purchase $321,624 +60,000 $5.36 60,000 31 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 60,000 shares purchased in the price range of $5.25 to $5.46 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.